Myriad Genetics | MYGN - Operating Expenses


Myriad Genetics reported $212.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 768.9M 44.3M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Illumina USD 899M 47M Jun/2026
J&J USD 17.83B 388M Jun/2026
Mettler Toledo International USD 739.77M 26.57M Jun/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.58B 88M Jun/2026
Quidel USD 646.2M 1.21B Jun/2026
Repligen USD 183M 8.72M Jun/2026
Revvity USD 603.55M 24.8M Jun/2026
Standard Biotools USD 30.56M 15.16M Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Veracyte USD 126.36M 6.37M Jun/2026
Waters USD 527M 592M Jun/2026